These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 10796734)

  • 1. Tamoxifen for relapse of ovarian cancer.
    Williams CJ
    Cochrane Database Syst Rev; 2000; (2):CD001034. PubMed ID: 10796734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen for relapse of ovarian cancer.
    Williams CJ
    Cochrane Database Syst Rev; 2001; (1):CD001034. PubMed ID: 11279703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen for relapse of ovarian cancer.
    Williams C; Simera I; Bryant A
    Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD001034. PubMed ID: 20238312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.
    Sharma R; Hamilton A; Beith J
    Cochrane Database Syst Rev; 2008 Oct; (4):CD004562. PubMed ID: 18843661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus).
    Hind D; Wyld L; Beverley CB; Reed MW
    Cochrane Database Syst Rev; 2006 Jan; (1):CD004272. PubMed ID: 16437480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic therapy for treating locoregional recurrence in women with breast cancer.
    Rauschecker H; Clarke M; Gatzemeier W; Recht A
    Cochrane Database Syst Rev; 2001; 2001(4):CD002195. PubMed ID: 11687148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamoxifen for early breast cancer.
    Early Breast Cancer Trialists' Collaborative Group
    Cochrane Database Syst Rev; 2001; (1):CD000486. PubMed ID: 11279694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative tamoxifen for ductal carcinoma in situ.
    Staley H; McCallum I; Bruce J
    Cochrane Database Syst Rev; 2012 Oct; 10():CD007847. PubMed ID: 23076938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian ablation for early breast cancer.
    Early Breast Cancer Trialists' Collaborative Group
    Cochrane Database Syst Rev; 2000; (2):CD000485. PubMed ID: 10796722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
    Lancet; 1998 May; 351(9114):1451-67. PubMed ID: 9605801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen in the treatment of recurrent ovarian carcinoma.
    Tropé C; Marth C; Kaern J
    Eur J Cancer; 2000 Sep; 36 Suppl 4():S59-61. PubMed ID: 11056321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taxane containing regimens for metastatic breast cancer.
    Ghersi D; Wilcken N; Simes J; Donoghue E
    Cochrane Database Syst Rev; 2003; (3):CD003366. PubMed ID: 12917963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
    Winter-Roach BA; Kitchener HC; Dickinson HO
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004706. PubMed ID: 19160239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women.
    Gibson LJ; Dawson C; Lawrence DH; Bliss JM
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003370. PubMed ID: 17253488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Chin J; Konje JC; Hickey M
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007245. PubMed ID: 19821400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of tamoxifen in asymptomatic patients with recurrent small-volume ovarian cancer.
    Markman M; Webster K; Zanotti K; Rohl J; Belinson J
    Gynecol Oncol; 2004 May; 93(2):390-3. PubMed ID: 15099951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy for advanced ovarian cancer. Advanced Ovarian Cancer Trialists Group.
    Stewart L;
    Cochrane Database Syst Rev; 2000; (2):CD001418. PubMed ID: 10796788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials.
    Fisher B; Jeong JH; Bryant J; Anderson S; Dignam J; Fisher ER; Wolmark N;
    Lancet; 2004 Sep 4-10; 364(9437):858-68. PubMed ID: 15351193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review.
    Rodgers RJ; Reid GD; Koch J; Deans R; Ledger WL; Friedlander M; Gilchrist RB; Walters KA; Abbott JA
    Hum Reprod; 2017 May; 32(5):1033-1045. PubMed ID: 28333356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials.
    Bernhard J; Luo W; Ribi K; Colleoni M; Burstein HJ; Tondini C; Pinotti G; Spazzapan S; Ruhstaller T; Puglisi F; Pavesi L; Parmar V; Regan MM; Pagani O; Fleming GF; Francis PA; Price KN; Coates AS; Gelber RD; Goldhirsch A; Walley BA
    Lancet Oncol; 2015 Jul; 16(7):848-58. PubMed ID: 26092816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.